NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYS: PFE) announced today that a post-marketing study assessing the efficacy and safety of varenicline (CHANTIX ® /CHAMPIX ®) in a population of smokers who ...

Smokers who are hospitalized for ACS may be especially receptive to advice on how to quit and to tools for keeping themselves off cigarettes. Now, research published online today in CMAJ shows that ...

Multiple lots of Chantix have been recalled "due to the presence of a nitrosamine, N-nitroso-varenicline, above the Pfizer established Acceptable Daily Intake (ADI) level," the company announced ...

The FDA has released the following: Pfizer is voluntarily recalling an additional four lots of Chantix 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, ...

(NEXSTAR) — Pfizer is voluntarily recalling the anti-smoking drug Chantix, a brand of varenicline, due to impurities that exceed approved levels, the Food and Drug Administration has announced. The ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc announced that it has updated the U.S. product labeling for CHANTIX® (varenicline), a prescription aid to smoking cessation treatment, to communicate important ...

Pfizer Inc. (NYSE: PFE) announced today the completion of a double-blind, placebo-controlled, randomized clinical trial designed to assess the efficacy and safety of CHANTIX/CHAMPIX (varenicline) 1 mg ...

February 1, 2007 (Oxford, UK) - Smokers who were given varenicline (Chantix, Pfizer), a nicotine receptor agonist, to help them stop smoking were three times more likely to quit than those who got an ...

Nicotine & Tobacco Research, Vol. 15, No. 11 (November 2013), pp. 1849-1857 (9 pages) Introduction: Concerns exist that varenicline may cause neuropsychiatric side effects. Some of these symptoms (e.g ...

TORONTO, ON — In an observational study of patients who were prescribed varenicline (Chantix in the United States/Champix elsewhere, Pfizer) to stop smoking, treatment was associated with increased ...

Please provide your email address to receive an email when new articles are posted on . RAUORA is a phase 3, head-to-head, noninferiority clinical trial designed to compare the effectiveness, safety ...

Pfizer is recalling batches of its anti-smoking medication Chantix after an increased level of impurities that can cause cancer were found in the drug. Included in the nationwide recall are two lots ...